Compare VALN & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALN | AEVA |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 820.0M | 766.0M |
| IPO Year | 2021 | N/A |
| Metric | VALN | AEVA |
|---|---|---|
| Price | $9.72 | $18.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $15.75 | ★ $26.50 |
| AVG Volume (30 Days) | 25.2K | ★ 1.6M |
| Earning Date | 11-20-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $211,089,992.00 | $15,154,000.00 |
| Revenue This Year | $3.64 | $87.44 |
| Revenue Next Year | $12.23 | $70.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.48 | ★ 89.90 |
| 52 Week Low | $4.20 | $2.52 |
| 52 Week High | $12.25 | $38.80 |
| Indicator | VALN | AEVA |
|---|---|---|
| Relative Strength Index (RSI) | 65.65 | 68.39 |
| Support Level | $8.77 | $12.30 |
| Resistance Level | $8.98 | $13.66 |
| Average True Range (ATR) | 0.35 | 1.06 |
| MACD | 0.14 | 0.19 |
| Stochastic Oscillator | 91.54 | 97.79 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.